Interactions of Hypotensive Agents and Vasodilating Drugs

Anon.: Anesthesia During Hypotensive Therapy, Lancet 2: 269 (July 30) 1966. (R).

Anon.: Three Drugs Alter Coombs' Test Results, J. Am. Med. Assoc. 202: 38 (Oct. 16) 1967. (R).

Anon.: A Second Report on Levodopa, Med. Letter Drugs Therapy, 11: 73 (Sept. 5) 1969. (R).

Boura A. L. A. Green A. F. : Adrenergic Neurone Blockade and Other Acute Effects Caused by N-Benzyl-N′N″-Dimethylquinidine and its Ortho-Chloro Derivative, Brit. J. Pharmacol. 20: 36 (Feb.) 1963 (OAT).

Breckenridge A. Dollery C. T. : Combined Action of Methyldopa and Bethanidine: Evidence for a Synergistic Effect, Lancet 1: 1074 (May 14) 1966. (OH).

Cardwell J. B. : Red Urine Associated with Methyldopa Treatment, Lancet 2: 326 (Aug. 9) 1969. (CH).

Chang C. C. Costa E. Brodie B. B. : Reserpine-Induced Release of Drugs from Sympathetic Nerve Endings, Life Sci. 3: 839, 1964. (R).

Chang C. C. Costa E. Brodie B. B. : Interactions of Guanethidine with Adrenergic Neurons, J. Pharmacol Exptl. Therap. 147: 303 (Mar.) 1965. (OA).

Contreras E. Tamayo L. : Effects of Drugs Acting in Relation to Sympathetic Junctions on the Analgesic Action of Morphine, Arch. Intern. Pharmacodyn. 160: 312 (Apr.) 1966. (OA).

Cooper B. : “Neo-Synephrine” (10%) Eye Drops, Med. J. Australia 2: 420 (Aug. 31) 1968. (CH).

Croft J. D. Jr. : Coombs' Test Positivity Induced by Drugs, Ann. Internal Med. 68: 176 (Jan.) 1968. (OCH).

Cross F. C. Canada A. T. Jr. Davis N. M. : The Effect of Certain Drugs on the Results of Some Common Laboratory Diagnostic Procedures, Am. J. Hosp. Pharm. 23: 235 (May) 1966. (R).

Davies T. S. : Monoamine Oxidase Inhibitors and Rauwolfia Compounds, Brit. Med. J. 2: 739 (Sept. 3) 1960. (CH).

Day M. D. Rand M. J. : Antagonism of Guanethidine and Bretylium by Various Agents, Lancet 2: 1282 (Dec. 15) 1962. (OA).

Day M. D. Rand M. J. : Antagonism of Guanethidine by Dexamphetamine and Other Related Sympathomimetic Amines, J. Pharm. Pharmacol. 14: 541 (Sept.) 1962. (OA).

Deshmanker B. S. Lewis J. A. : Ventricular Tachycardia Associated with the Administration of Methylphenidate During Guanethidine Therapy, Can. Med. Assoc. J. 97: 1166 (Nov. 4) 1967. (CH).

Dollery C. T. : Physiological and Pharmacological Interactions of Anti-Hypertensive Drugs, Proc. Roy. Soc. Med. 58: 983 (Nov.) 1965. (R).

Dunphy T. W. : The Pharmacist's Role in the Prevention of Adverse Drug Interactions, Am. J. Hosp. Pharm. 26: 366 (July) 1969. (R).

Eble J. N. Rudzik A. D. : The Blockade of the Pressor Response to Tyramine by Amphetamine in the Reserpine-Treated Dog, J. Pharmacol. Exptl. Therap. 153: 62 (July) 1966. (OA).

Gelder M. G. Vane J. R. : Interaction of the Effects of Tyramine, Amphetamine and Reserpine in Man, Psychopharmacologia 3: 231, 1962. (OH).

Gokhale S. D. Gulati O. D. Udwadia B. P. : Antagonism of the Adrenergic Neurone Blocking Action of Guanethidine by Certain Antidepressant and Antihistamine Drugs, Arch. Intern. Pharmacodyn. 160: 321 (Apr.) 1966. (OA).

Gulati O. D. : Antagonism of Adrenergic Neuron Blockade in Hypertensive Subjects, Clin. Pharmacol. Therap. 7: 510 (July-Aug.) 1966. (OH).

Gupta K. K. Lillicrap C. A. : Guanethidine and Diabetes, Brit. Med. J. 2: 697 (June 15) 1968. (CH).

Hussar D. A. : Tabular Compilation of Drug Interactions, Am. J. Pharm. 141: 109 (July-Aug.) 1969. (R).

Johnson P. : Treatment of Hypertension with Methyldopa, Brit. Med. J. 1: 133–7 (Jan.) 1966. (OH).

Kaumann A. Basso N. Aramendia P. : The Cardiovascular Effects of N-(2-Methylaminopropyliminodibenzyl)-HO (Desmethylimipramine) and Guanethidine, J. Pharmacol. Exptl. Therap. 147: 54 (Jan.) 1965. (OAT).

Laurence D. R. Nagle R. E. : The Effects of Bretylium and Guanethidine on the Pressor Responses to Noradrenaline and Angiotensin, Brit. J. Pharmacol. 21: 403 (Dec.) 1963. (OH).

Leishman A. W. D. Matthews H. L. Smith A. J. : Antagonism of Guanethidine by Imipramine, Lancet 1: 112 (Jan. 12) 1963. (CH).

Cowling D. C. Hurley T. H. : Drug-Induced Autoimmune Disease: Haemolytic Anaemia and Lupus Cells After Treatment with Methyl Dopa, Med. J. Australia 2: 1047 (Dec. 7) 1968. (CH).

Malone M. H. Hochman H. I. Nieforth K. A. : Desoxycholic Acid Enhancement of Orally Administered Reserpine, J. Pharm. Sci. 55: 972–4 (Sept.) 1966. (OA).

Mitchell J. R. Arias L. Oates J. A. : Antagonism of the Antihypertensive Action of Guanethidine Sulfate by Desipramine Hydrochloride, J. Am. Med. Assoc. 202: 973 (Dec. 4) 1967. (OH).

Ominsky A. J. Wollman H. : Hazards of General Anesthesia in the Reserpinized Patient, Anesthesiology 30: 433 (Apr.) 1969. (R).

Paykel E. S. : Hallucinosis on Combined Methyldopa and Pargyline, Brit. Med. J. 1: 803 (Mar. 26) 1966. (CH).

Roche, Matulane (Procarbazine HCl), Roche Literature, Aug. 1969.

Sjpqyist F. : Psychotropic Drugs (2) Interaction Between Monoamine Oxidase (MAO) Inhibitors and Other Substances, Proc. Roy. Soc. 58: 967 (Nov.) 1965. (R).

Skinner C. Coull D. C. Johnston A. W. : Antagonism of Hypotensive. Action of Bethanidine and Debrisoquine by Tricyclic Antidepressants, Lancet 2: 564 (Sept. 13) 1969. (CH).

Stone C. A. : Antagonism of Certain Effects of Catecholamine-Depleting Agents by Antidepressant and Related Drugs, J. Pharmacol. Exptl. Therap. 144: 196 (May) 1964. (OA).

Thurm R. H. : AMD and Positive Direct Coombs' Test, New Engl. J. Med. 277: 550 (Sept. 7) 1967. (H).

White A. G. : Methyldopa and Amitriptyline, Lancet 2: 441 (Aug. 28) 1965. (CH).

White R. P. : Acute Ergotropic Response Induced by Reserpine and Mephentermine, Intern. J. Neuropharmacol. 5: 143–54 (Mar.) 1966. (OA).

Wilson R. Long C. : Action of Bretylium Antagonized by Amphetamine, Lancet 2: 262 (July 30) 1960 (OH).

Yelnosky J. McGill J. S. Mastrangelo A. S. : A Comparison of the Blood Pressure Effects of Reserpine in Dogs Pretreated with Amphetamine or Tyramine, Arch. Intern. Pharmacodyn. 159: 406–23 (Feb.) 1966. (OA).

Schelling J. Lasagna L. : Study of Cross Tolerance to Circulatory Effects of Organic Nitrates, Clin. Pharmacol. Therap. 8: 256 (Mar.-Apr.) 1967.

Shafer N. : Hypotension Due to Nitroglycerin Combined with Alcohol, New Engl. J. Med. 273: 1169 (Nov. 18) 1965.

Anon.: Adverse Effects of Drugs on the Liver and Their Detection by Laboratory Tests, Med. Let. Drugs Therap. 11: 17 (Mar. 7) 1969.

Carlsson A. Lindgvist M. : The Interference of Tetrabenazine, Benzquinamide and Prenylamine with the Action of Reserpine, Acta Pharmacol. (Kobenhavn) 24: 112–20, 1966. (OA).

Duvernoy W. F. C. : Positive Phentolamine Test in Hypertension Induced by A Nasal Decongestant, New Engl. J. Med. 280: 877 (Apr. 17) 1969. (CH).

Payne J. P. Rowe G. G. : The Effects of Mecamylamine in the Cat As Modified by the Administration of Carbon Dioxide, Brit. J. Pharmacol. 12: 456 (Dec.) 1957. (OA).

Sharma P. L. : Interaction of Adrenergic Alpha- and Beta-Receptor Blocking Agents on the Blood Pressure Response to Adrenaline and Noradrenaline, Quart. J. Exptl. Physiol. 51: 256–61 (Oct.) 1966. (OA).

Intern, Drug Therapy Newsletter, Tricyclic Antidepressants Antagonize the Antihypertensive Effects of Guanethidine, June, 1969.

Afonso S. O'Brien G. S. : Enhancement of Coronary Vasodilator Action of Adenosine Triphosphate by Dipyridamole, Circulation Res. 20: 403–8 (Apr.) 1967.

Block L. H. Lamy P. P. : Legend Drugs with O-T-C Drugs. Therapeutic Incompatibilities, J. Am. Pharm. Assoc. NS8: 66 (Feb.) 1968.

Doeglas H. M. G. Nater J. P. : Histamine in Foods Causing False Positive Scratch Tests, J. Allergy 42: 164 (Sept.) 1968.

Kay A. W. : Effect of Large Doses of Histamine on Gastric Secretion of HCL. An Augmented Histamine Test, Brit. Med. J. 2: 77 (July 11) 1953. (OH).

Stafford A. : Potentiation of Adenosine and the Adenine Nucleotides by Dipyridamole, Brit. J. Pharmacol. 28: 218–27 (Nov.) 1966. (OAT).